Leef Brands LEEEF
OTC LEEEF
$0.20 0.00 (-1.22%)
As of: Aug 21, 2026 · 3:51 PM EDT

Leef Brands (LEEEF) Liabilities and Shareholders Equity (2024 - 2026)

Leef Brands (LEEEF) posted Liabilities and Shareholders Equity of $41.9 million for Q1 2026, up 14.96% sequentially from $36.4 million in Q4 2025.

Leef Brands (LEEEF) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

Leef Brands has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $41.9 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $41.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121.2 million (changed N/A YoY) and the FY2025 annual result came in at $36.4 million, down 15.3% from the prior year.
  • Liabilities and Shareholders Equity climbed to $41.9 million in Q1 2026 per LEEEF's latest filing, from $36.4 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $43.0 million in Q4 2024 and troughed at $36.4 million in Q4 2025.
  • A 3-year average of $40.4 million and a median of $41.9 million in 2026 frame the typical range for Liabilities and Shareholders Equity.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 15.3% in 2025, down 15.3% in 2025.
  • Over 3 years, Liabilities and Shareholders Equity stood at $43.0 million in 2024, then fell by 15.3% to $36.4 million in 2025, then increased by 14.96% to $41.9 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $41.9 million, $36.4 million, and $43.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 39.86 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 6.18 Bn
10 Leef Brands 58.70 Mn 53.75 Mn 2.41 Mn 52.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 52.41 Mn
Mar 31, 2026 41.85 Mn
Dec 31, 2025 36.40 Mn
Dec 31, 2024 42.98 Mn